Melanoma Focus Virtual Regional Meeting

Friday 12th May 2023

Organised by: Professor Marianne Nicolson, Consultant Medical Oncologist, Raigmore Hospital, Inverness

Location: Virtual

Friday, 12th May 20239:00 am – 5:30 pm

The Royal Colleges of Physicians of the United Kingdom have awarded up to 6 CPD credits. The Royal College of Surgeons of England has awarded up to 5.5 CPD points and the British Association of Plastic, Reconstructive and Aesthetic Surgeons have awarded up to 7 CME points.


If you are unsure about your membership, please email



Welcome/Introductions (Dr Mark Harries / Susanna Daniels/Professor Marianne Nicolson)


Neoadjuvant treatment of melanoma  

Professor Paolo Ascierto, Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione G. Pascale, Naples


Session 1: Progress in stage 2/3 melanoma

Chair: Professor Marianne Nicolson, Consultant Medical Oncologist, Raigmore Hospital, Inverness

10:10 – 10:40

Adjuvant therapy for resected melanoma – where are we now?

Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust

10:40 – 11:10

SLNB: An update on accuracy and eligibility

Mr Neil Cahoon, Consultant Plastic Surgeon, Edinburgh

11:10 – 11:25


11:25 – 13:30

Pharma Exhibition Area / Posters

11:30– 12:30

Pharma Sponsored Symposium: IMMUNOCORE


KIMMTRAK (Tebentafusp) – A New Treatment Option for patients with HLA-A*02:01 positive metastatic Uveal Melanoma


NHS Real World Experience and Future Service Considerations

13:30 – 14:45

Session 2: Optimising diagnosis today and new horizons for tomorrow 

Chair: Dr Ewan Brown, Consultant Medical Oncologist, Western General Hospital, Edinburgh

13:30 – 14:00

Diagnostic dilemmas in melanocytic pathology

Dr Asok Biswas, Consultant Dermatopathologist and Honorary Senior Lecturer, Weston General Hospital and The University of Edinburgh

14:00 – 14:30

Transcriptional heterogeneity in melanoma and residual disease

Dr Jana Travnickova, Research Fellow, MRC Human Genetics Unit and Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Edinburgh

14:30 – 14:45


14:45 – 14:55

Comfort Break

14:55 – 16:10

Session 3: Teledermatology practice changes

Chair: Mr Kaz Rahman, Consultant Plastic Surgeon, NHS Grampian & Clinical Director for Skin Cancer, North Cancer Alliance

14:55 – 15:25

Enhancement of clinical practice through teledermatology

Dr Alyson Bryden, Consultant Dermatologist, Ninewells Hospital, Dundee

15:25 – 15:55

Digital healthcare intervention for melanoma survivors: the next steps?

Professor Peter Murchie, Professor of General Practice, University of Aberdeen

15:55 – 16:10


16:15 – 17:25

Session 4:  MDT – Management of metastatic uveal melanoma (case-based discussions)

Chair: Dr Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre

– Dr Paul Cauchi, Consultant Ophthalmologist, Clinical Director of Ophthalmology for NHS
Greater Glasgow and Clyde
– Professor Jeff Evans, Professor of Translational Cancer Research and Clinical Lead/Deputy
Director of the Institute of Cancer Sciences, University of Glasgow, Honorary Consultant in
Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow
– Dr Ashita Waterston Medical Oncologist, Beatson West of Scotland Cancer Centre,
– Dr Matthew Wheater, Consultant Medical Oncologist, University Hospital Southampton
NHS Foundation Trust

17:25 – 17:30

Concluding Remarks and Close

Dr Mark Harries, Chairman Melanoma Focus, Professor Marianne Nicolson, Organiser